primary cutaneous anaplastic large cell lymphoma
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
leukemia |
| gptkbp:affects |
gptkb:skin
|
| gptkbp:distinctFrom |
systemic anaplastic large cell lymphoma
|
| gptkbp:firstDescribed |
1985
|
| gptkbp:hasCellMarker |
gptkb:CD30
|
| gptkbp:hasRelapseRate |
up to 40%
|
| https://www.w3.org/2000/01/rdf-schema#label |
primary cutaneous anaplastic large cell lymphoma
|
| gptkbp:ICD-10_code |
C84.4
|
| gptkbp:medianAge |
60 years
|
| gptkbp:prognosis |
generally favorable
|
| gptkbp:rarity |
true
|
| gptkbp:subspecies |
CD30+ T-cell lymphoma
|
| gptkbp:symptom |
skin nodules
red or violaceous plaques ulcerated lesions |
| gptkbp:treatment |
gptkb:brentuximab_vedotin
radiation therapy surgical excision systemic chemotherapy |
| gptkbp:bfsParent |
gptkb:ALK-positive_anaplastic_large_cell_lymphoma
gptkb:brentuximab_vedotin |
| gptkbp:bfsLayer |
7
|